These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The effect of selenium and zinc on CD4(+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial. Hadadi A; Ostovar A; Edalat Noor B; Rasoolinejad M; Haji Abdolbaghi M; Yousefi S; Khalili H; Manshoori G; Khashayar P; Alipour Z; Safari N Acta Clin Belg; 2020 Jun; 75(3):170-176. PubMed ID: 30888253 [No Abstract] [Full Text] [Related]
9. Cocaine reduces thymic endocrine function: another mechanism for accelerated HIV disease progression. Rafie C; Campa A; Smith S; Huffman F; Newman F; Baum MK AIDS Res Hum Retroviruses; 2011 Aug; 27(8):815-22. PubMed ID: 21142650 [TBL] [Abstract][Full Text] [Related]
10. Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy? Kirk O; Lundgren JD; Pedersen C; Nielsen H; Gerstoft J AIDS; 1999 Sep; 13(13):1647-51. PubMed ID: 10509565 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China. Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553 [TBL] [Abstract][Full Text] [Related]
12. Immunological evaluation of patients with beta-thalassemia major. Consolini R; Calleri A; Legitimo A; Massei F Acta Haematol; 2001; 105(1):7-12. PubMed ID: 11340247 [TBL] [Abstract][Full Text] [Related]
13. AIDS: Part II. Kessler HA; Bick JA; Pottage JC; Benson CA Dis Mon; 1992 Oct; 38(10):691-764. PubMed ID: 1396036 [TBL] [Abstract][Full Text] [Related]
14. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. Schneider MM; Borleffs JC; Stolk RP; Jaspers CA; Hoepelman AI Lancet; 1999 Jan; 353(9148):201-3. PubMed ID: 9923876 [TBL] [Abstract][Full Text] [Related]
15. [A changed pattern of opportunistic infections and malignancies in HIV-seropositive patients after the introduction of intensive anti-HIV-combination therapy]. Borleffs JC; Schneider MM; Hoepelman IM Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2395-9. PubMed ID: 9864534 [TBL] [Abstract][Full Text] [Related]
16. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire. Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563 [TBL] [Abstract][Full Text] [Related]
17. HIV infection and AIDS. Lloyd A P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558 [TBL] [Abstract][Full Text] [Related]
18. Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution. Arici C; Ripamonti D; Ravasio V; Maggiolo F; Rizzi M; Finazzi MG; Suter F Int J STD AIDS; 2001 Sep; 12(9):573-81. PubMed ID: 11516366 [TBL] [Abstract][Full Text] [Related]
19. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era. Mowatt L West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590 [TBL] [Abstract][Full Text] [Related]